We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Brexit – Liberation or Limitation for the Life Sciences Sector?

Article   Dec 11, 2019 | by Fiona Maini

 
Brexit – Liberation or Limitation for the Life Sciences Sector?
 
 
 

RELATED ARTICLES

Nanoparticle Drug Delivery Could Offer More Effective Pain Relief Than Opioids

Article

Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.

READ MORE

Exploring the Medicinal Benefits of Cannabis Within UK Pharmaceuticals

Article

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.

READ MORE

The Importance of Understanding Target–Protein Interactions in Drug Discovery

Article

You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE